Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemopatch Implication After Axillary Dissection for Breast Cancer: a Randomized Clinical Study

NCT06744998 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06744998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06744998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemopatch Implication After Axillary Dissection for Breast Cancer: a Randomized Clinical Study
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
March 31, 2026
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer